These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
35. Effects of vitreomacular adhesion on anti-vascular endothelial growth factor treatment for polypoidal choroidal vasculopathy. Cho HJ, Baek JS, Lee DW, Cho SW, Kim CG, Kim JW. Retina; 2013 May; 33(10):2126-32. PubMed ID: 23609123 [Abstract] [Full Text] [Related]
36. Influence of the vitreomacular interface on outcomes of ranibizumab therapy in neovascular age-related macular degeneration. Mayr-Sponer U, Waldstein SM, Kundi M, Ritter M, Golbaz I, Heiling U, Papp A, Simader C, Schmidt-Erfurth U. Ophthalmology; 2013 Dec; 120(12):2620-2629. PubMed ID: 23870300 [Abstract] [Full Text] [Related]
38. Subfoveal Lucency after Treatment of Vitreomacular Traction without Macular Hole in the Phase 3 Trials of Ocriplasmin Vitreolysis. Thomas AS, Folgar FA, Jaffe GJ, Toth CA, Mahmoud TH. Ophthalmol Retina; 2019 Jan; 3(1):42-52. PubMed ID: 30929816 [Abstract] [Full Text] [Related]
39. ANATOMICAL AND FUNCTIONAL OUTCOMES OF SYMPTOMATIC IDIOPATHIC VITREOMACULAR TRACTION: A Natural History Study From the Pan American Collaborative Retina Study Group. Wu L, Zas M, Berrocal MH, Arevalo JF, Figueroa M, Rodriguez F, Serrano M, Graue F, Alezzandrini A, Gallego-Pinazo R, Roca JA, Iglicki M, Dalma-Weishauz J, Kozak I, Collado A, Badal J, Maia M, Salcedo-Villanueva G, Quiroz-Mercado H, Fromow-Guerra J, Lozano-Rechy D, Avila M, Chhablani J. Retina; 2016 Oct; 36(10):1913-8. PubMed ID: 26966868 [Abstract] [Full Text] [Related]